- Tytuł:
- Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.
- Autorzy:
- Źródło:
- European journal of gynaecological oncology [Eur J Gynaecol Oncol] 2023 Feb; Vol. 44 (1), pp. 17-25. Date of Electronic Publication: 2023 Feb 14.
- Typ publikacji:
- Journal Article
Czasopismo naukowe